Red blood cell transfusion triggers in acute leukemia: a randomized pilot study

Area of Science:

• Hematology
• Oncology
• Clinical Trials

Background:

• Red blood cell (RBC) transfusion thresholds lack extensive randomized trial data in hematologic malignancies.
• This pilot study investigates a restrictive versus a liberal transfusion strategy in acute leukemia patients.

Purpose of the Study:

• To assess the feasibility of conducting a larger randomized trial on transfusion thresholds in acute leukemia.
• To evaluate the safety and efficacy of restrictive transfusion strategies.

Main Methods:

• A randomized (2:1) trial comparing a restrictive (7 g/dL hemoglobin) to a liberal (8 g/dL hemoglobin) transfusion trigger.
• Feasibility assessed by patient consent, tolerance of restrictive trigger, low crossover rates, and safety.
• Secondary outcomes included fatigue, bleeding, and transfusion units.

Main Results:

• Feasibility criteria were met, with 90 patients consented and randomized.
• The restrictive (LOW) arm received significantly fewer RBC units (8.0) compared to the liberal (HIGH) arm (11.7) (p=0.0003).
• No significant differences in bleeding events or neutropenic fevers were observed between arms.

Conclusions:

• This study demonstrates the feasibility and safety of a restrictive red blood cell transfusion strategy in acute leukemia.
• Further research is needed to confirm the equivalence of restrictive and liberal transfusion thresholds in this patient population.